semaglutide candidate Weight Loss Program Bellevue & Kirkland GLP-1 medications are about more

Journal of the Endocrine Society, 5 (Suppl 1), A7

For GLP-1 (glucagon-like peptide-1) drugscurrently in the spotlight for obesity treatmentthe key differentiator is not the active ingredient but the delivery method

Think of it like this: Novo Nordisk developed semaglutide, got it approved for diabetes under the name Ozempic, then later reformulated it at a higher dose and got separate FDA approval for weight loss under the name Wegovy

Dose adjustments or slow titration If diarrhoea becomes persistent or problematic, clinicians often recommend slowing down the titration schedule

A randomized, controlled trial of liraglutide for adolescents with obesity